Serum BCMA levels to predict outcomes for patients with MGUS and smoldering multiple myeloma (SMM).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mayo Clinic, Institute for Myeloma & Bone Cancer Research
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2954021663
